newsfilter
← Latest News
GlobeNewswire·

Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002

SARASOTA, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Oragenics Inc. (NYSE:OGEN), a company focused on developing new treatments for brain-related health conditions, has completed a key study for their new concussion drug,